Board of Directors Management Team Stock Exchanges J. Michael Pearson J. Michael Pearson New York Stock Exchange and Toronto Chairman and Chief Executive Officer Chairman and Chief Executive Officer Stock Exchange Valeant Pharmaceuticals International, Inc. NYSE/TSX Trading Symbols Howard B. Schiller Common Stock: VRX Robert A. Ingram Executive Vice President and Chief Lead Director, Valeant Pharmaceuticals Financial Officer Principal Transfer Agent International, Inc. & Registrar Partner, Hatteras Venture Partners Rajiv De Silva Valeant Pharmaceuticals International, Committees: Nominating and Corporate President, Valeant Pharmaceuticals Inc.’s designated transfer agent is Cana- Governance, Talent and Compensation International, Inc. and Chief Operating dian Stock Transfer. The transfer agent Officer, Specialty Pharmaceuticals is responsible for maintaining all records Ronald H. Farmer of registered stockholders (including Managing Director of Mosaic Capital Partners Robert Chai-Onn change of address, telephone number, Committees: Operations, Talent and Executive Vice President, General Counsel, and name), canceling or issuing stock Compensation Corporate Secretary and Corporate certificates and resolving problems Business Development related to lost, destroyed or stolen certifi- Theo Melas-Kyriazi cates. If you are a registered stockholder Chief Financial Officer, Levitronix LLC Brian M. Stolz of Valeant Pharmaceuticals International, Committees: Operations (Chairperson), Executive Vice President of Administration Inc. and need to change your records Finance and Transactions, Audit and Risk and Chief Human Capital Officer pertaining to stock, please contact the Transfer Agent listed below: G. Mason Morfit Dr. Susan T. Hall, Ph.D. Partner, ValueAct Capital Senior Vice President, Global Head of Canadian Stock Transfer Committees: Finance and Transactions Research and Development P.O. Box 700 (Chairperson), Operations, Talent and Station B Compensation Richard K. Masterson Montreal, QC H3B 3K3 President and Chief Operating Officer of Canada Dr. Laurence E. Paul Valeant International (Barbados) SRL Fax: 888-249-6189 Founding Principal, Laurel Crown Capital LLC Committees: Finance and Transactions, Corporate Information Phone (for all security transfer inquiries): Operations, Talent and Compensation Corporate Headquarters 1-800-387-0825 or 416-682-3860 4787 Levy Street Robert N. Power Montreal, Quebec H4R 2P9 Website: Corporate Director Canada www.canstockta.com Committees: Talent and Compensation Phone: 514.744.6792 (Chairperson), Nominating and Corporate Fax: 514.744.6272 Governance, Operations www.valeant.com
Norma A. Provencio Independent Auditors
President and Owner, Provencio Advisory PricewaterhouseCoopers LLP ia.
n Services Inc.
Committees: Audit and Risk (Chairperson), Investor and Media Relations ifor
l Special Independent (Chairperson), You may request a copy of documents at a
C Operations no cost by contacting: Laurie W. Little Lloyd M. Segal Vice President, Investor Relations Equity Partner, Persistence Capital Partners (949) 461-6002
osta Mesa, Committees: Nominating and Corporate [email protected]
C
n Governance (Chairperson), Finance Email updates are also available i n
a and Transactions through the Investor Relations page y
at Valeant’s website at www.valeant.com.
to S Katharine B. Stevenson by Corporate Director ed Committees: Audit and Risk, Finance
gn and Transactions, Nominating and esi